Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers

NCT03402230 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03402230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
February 20, 2018
Completion date
July 24, 2022
Enrollment
49 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking-related carcinoma, tobacco-related carcinoma